GRAVITI Study on Guselkumab's Efficacy and Safety for Moderate to Severe Crohn's Disease. Wang H, Xue K, Kong Y, Shen X, et al. Gastroenterology 2025 Oct 10:S0016-5085(25)06110.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Wang H, Xue K, Kong Y, Shen X, et al. GRAVITI Study on Guselkumab's Efficacy and Safety for Moderate to Severe Crohn's Disease. Gastroenterology 2025 Oct 10:S0016-5085(25)06110.
PMID: 41077313